Pharmacogenetics of carbamazepine
Carbamazepine (CMZ) is a drug from the group of anticonvulsants, similar in chemical structure to tricyclic antidepressants. CMZ is widely used for mental disorders and neurological diseases. The lecture discusses the safety of CMZ in respect to personalized medicine, while considering the pharmacog...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2020-01-01
|
| Series: | Эпилепсия и пароксизмальные состояния |
| Subjects: | |
| Online Access: | https://www.epilepsia.su/jour/article/view/503 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849395602695127040 |
|---|---|
| author | N. A. Shnayder E. N. Bochanova D. V. Dmitrenko R. F. Nasyrova |
| author_facet | N. A. Shnayder E. N. Bochanova D. V. Dmitrenko R. F. Nasyrova |
| author_sort | N. A. Shnayder |
| collection | DOAJ |
| description | Carbamazepine (CMZ) is a drug from the group of anticonvulsants, similar in chemical structure to tricyclic antidepressants. CMZ is widely used for mental disorders and neurological diseases. The lecture discusses the safety of CMZ in respect to personalized medicine, while considering the pharmacogenetic profile of the patient.The authors declare about the absence of conflict of interest with respect to this publication. All authors contributed equally to this article. |
| format | Article |
| id | doaj-art-b15e9fabcf9d48e78adcc73aae3ec8d4 |
| institution | Kabale University |
| issn | 2077-8333 2311-4088 |
| language | Russian |
| publishDate | 2020-01-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Эпилепсия и пароксизмальные состояния |
| spelling | doaj-art-b15e9fabcf9d48e78adcc73aae3ec8d42025-08-20T03:39:32ZrusIRBIS LLCЭпилепсия и пароксизмальные состояния2077-83332311-40882020-01-0111436437810.17749/2077-8333.2019.11.4.364-378469Pharmacogenetics of carbamazepineN. A. Shnayder0E. N. Bochanova1D. V. Dmitrenko2R. F. Nasyrova3Bekhterev National Medical Research Center of Psychiatry and NeurologyBekhterev National Medical Research Center of Psychiatry and Neurology; Prof. V. F. Voino-Yasenetsky Krasnoyarsk State Medical UniversityProf. V. F. Voino-Yasenetsky Krasnoyarsk State Medical UniversityBekhterev National Medical Research Center of Psychiatry and NeurologyCarbamazepine (CMZ) is a drug from the group of anticonvulsants, similar in chemical structure to tricyclic antidepressants. CMZ is widely used for mental disorders and neurological diseases. The lecture discusses the safety of CMZ in respect to personalized medicine, while considering the pharmacogenetic profile of the patient.The authors declare about the absence of conflict of interest with respect to this publication. All authors contributed equally to this article.https://www.epilepsia.su/jour/article/view/503carbamazepineefficacysafetyadverse drug reactionpharmacogeneticspharmacokineticspharmacodynamics |
| spellingShingle | N. A. Shnayder E. N. Bochanova D. V. Dmitrenko R. F. Nasyrova Pharmacogenetics of carbamazepine Эпилепсия и пароксизмальные состояния carbamazepine efficacy safety adverse drug reaction pharmacogenetics pharmacokinetics pharmacodynamics |
| title | Pharmacogenetics of carbamazepine |
| title_full | Pharmacogenetics of carbamazepine |
| title_fullStr | Pharmacogenetics of carbamazepine |
| title_full_unstemmed | Pharmacogenetics of carbamazepine |
| title_short | Pharmacogenetics of carbamazepine |
| title_sort | pharmacogenetics of carbamazepine |
| topic | carbamazepine efficacy safety adverse drug reaction pharmacogenetics pharmacokinetics pharmacodynamics |
| url | https://www.epilepsia.su/jour/article/view/503 |
| work_keys_str_mv | AT nashnayder pharmacogeneticsofcarbamazepine AT enbochanova pharmacogeneticsofcarbamazepine AT dvdmitrenko pharmacogeneticsofcarbamazepine AT rfnasyrova pharmacogeneticsofcarbamazepine |